Commentary

Video

ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event

The first SightLine meeting, held pre-ASCRS, reveals insights on physician-industry relationships, mentorship opportunities, and the practical applications of AI in healthcare.

At the inaugural SightLine meeting—held the day prior to the 2025 American Society of Cataract and Refractive Surgery annual meeting in Los Angeles, California—Michael Rivers, MD, shared some of his takeaways, particularly around the evolving relationship between physicians and industry. “The aspect of SightLine that I thought was very interesting was that people from industry talked about some of their challenges in industry, and how they dealt with that,” Rivers noted. The transparency from industry partners, such as candid discussions about events like a lens recall, helped bridge empathy and understanding. “As a physician, we feel terrible about [recalls] for our patients. But hearing industry insiders, we understand that it's really terrible for them, too... That was very heartening.”

Rivers spoke on a panel focused on pathways for physicians to engage with industry. The session highlighted roles such as chief medical officers, private equity advisors, and physician-executives like Rivers, who is now working in software. A key takeaway: mentorship. “These were all older physicians who, in general, were very interested in being mentors… we talked about ways that younger doctors could become involved in industry and different avenues that would be open to them.”

Artificial intelligence was another prominent theme. Rivers emphasized pragmatism over hype: “It is important to understand that AI is a tool... just like GPS.” He shared how AI is being practically applied to reduce administrative burdens. One example: an AI tool that pre-screens insurance claims for potential denials. “It flags them and alerts the billing team… Here’s an area where we’re augmenting the intelligence of the billing team, which I think is really exciting.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
© 2025 MJH Life Sciences

All rights reserved.